Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes.
Simon R HellerTadej BattelinoTimothy S BaileyThomas R PieberUlrike HoevelmannLeona Plum-MörschelAnita E MelgaardRonnie AronsonLinda A DiMeglioThue JohansenThomas DannePublished in: Diabetes, obesity & metabolism (2023)
Dasiglucagon was well tolerated and effective as a rapid rescue agent for insulin-induced SH in people with T1D.